Ensign Peak Advisors
CBAY

Ensign Peak Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Ensign Peak Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,700
Closed -$1.1M – 1767
2023
Q4 		$1.1M Buy
46,700
+5,450
+13% +$129K ﹤0.01% 1297
2023
Q3 		$615K Buy
+41,250
New +$615K ﹤0.01% 1519